Table of Contents
Introduction: Anxiolytic vs Tissue Repair Neuroprotection
Selank and BPC-157 both demonstrate neuroprotective properties but serve very different research purposes. Selank is a synthetic analog of the immunomodulatory peptide tuftsin, designed specifically for anxiolytic and nootropic effects. BPC-157 is a gastric pentadecapeptide whose neuroprotective activity is one facet of its broad tissue repair profile.
Selank calms the anxious brain; BPC-157 heals the damaged brain (and body). They address anxiety-related vs injury-related neurological research questions.
Selank: The Anxiolytic Nootropic Peptide
Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic peptide based on the endogenous immunopeptide tuftsin (Thr-Lys-Pro-Arg) with an added Pro-Gly-Pro C-terminal extension for stability. Developed at the Institute of Molecular Genetics (Russian Academy of Sciences) alongside Semax, Selank is approved in Russia as an anxiolytic medication.
Mechanism
- GABA system modulation: Enhances GABAergic inhibition without direct GABA-A receptor binding (avoids sedation and addiction)
- Enkephalin metabolism: Inhibits enkephalin degradation, prolonging endogenous opioid anxiolytic effects
- BDNF expression: Upregulates brain-derived neurotrophic factor (shared with Semax)
- Monoamine modulation: Balances serotonin and norepinephrine signaling
- IL-6 regulation: Modulates interleukin-6 expression in the brain (immune-neuro interface)
- Intranasal delivery: Administered intranasally for CNS access
BPC-157: Tissue Healer With Neural Effects
BPC-157‘s neurological activity includes dopaminergic neuron protection (MPTP models), peripheral nerve regeneration, GABAergic system interaction with anticonvulsant properties, serotonin system modulation, and NO-mediated neuroprotection (PMID: 24382513).
Mechanism Comparison
| Feature | Selank | BPC-157 |
|---|---|---|
| Origin | Tuftsin analog (immunopeptide) | Human gastric juice |
| Primary Focus | Anxiolytic + nootropic | Tissue repair (neuro secondary) |
| GABA Effects | Enhanced GABAergic inhibition (primary) | GABAergic interaction (secondary) |
| Anxiety | Primary indication (approved in Russia) | Not primary |
| Tissue Repair | Not applicable | Extensive (gut, tendon, muscle, nerve) |
| Immune Effects | Yes (tuftsin-derived immunomodulation) | Indirect (cytoprotection) |
| Administration | Intranasal | Injectable or oral |
Choosing the Right Peptide
Choose Selank when:
- Anxiety and stress-related behavior are the primary research endpoints
- GABA system modulation without sedation is desired
- Immune-neuro interactions are being studied
- A non-addictive anxiolytic compound is needed
Choose BPC-157 when:
- Nerve injury repair or dopaminergic protection is the focus
- Systemic tissue healing alongside neuroprotection is needed
- Oral administration is preferred
- The research question is about healing, not anxiety
For dedicated cognitive research, Semax (Selank’s sibling compound) offers direct BDNF-mediated cognitive enhancement without the anxiolytic focus.
Frequently Asked Questions
Is Selank addictive like benzodiazepines?
No. Selank modulates GABAergic signaling indirectly rather than directly binding GABA-A receptors (the mechanism that makes benzodiazepines addictive). It enhances inhibitory tone without the sedation, tolerance, or dependence associated with benzodiazepines. This non-addictive anxiolytic profile was a key design goal.
Can Selank and BPC-157 be combined?
Yes. They target different systems — Selank modulates GABA/enkephalin pathways while BPC-157 works through NO/growth factors. A combination could address anxiety (Selank) alongside tissue healing and neuroprotection (BPC-157). Their different routes (intranasal vs injectable/oral) make co-administration straightforward.
What is the difference between Selank and Semax?
Selank is primarily anxiolytic (anti-anxiety) with secondary nootropic effects. Semax is primarily nootropic (cognitive enhancement) with secondary neuroprotective effects. Both were developed at the same institute and share some mechanisms (BDNF upregulation), but their primary indications differ. Selank is derived from tuftsin (an immunopeptide); Semax is derived from ACTH (a neuroendocrine peptide).
References
- Seiwerth S, et al. BPC 157’s effect on healing. J Physiol Pharmacol. 2014;65(2):299-307. PMID: 24382513
- Kozlovskii II, et al. The role of the GABA-ergic system in the mechanism of action of Selank. Bull Exp Biol Med. 2002;134(2):168-170.
- Kost NV, et al. Effect of Selank on enkephalin degradation enzymes. Bull Exp Biol Med. 2001;131(4):315-317.
About Proxiva Labs: We supply research-grade BPC-157 and Semax for neuroprotective and cognitive research. Browse the complete research peptide catalog.
All products are sold strictly for research purposes only. Not for human consumption.